These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 14605244)

  • 1. Nimesulide, a cyclooxygenase-2 preferential inhibitor, impairs renal function in the newborn rabbit.
    Prévot A; Mosig D; Martini S; Guignard JP
    Pediatr Res; 2004 Feb; 55(2):254-60. PubMed ID: 14605244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of COX-2-derived metabolites in regulation of the renal hemodynamic response to norepinephrine.
    Llinás MT; López R; Rodríguez F; Roig F; Salazar FJ
    Am J Physiol Renal Physiol; 2001 Nov; 281(5):F975-82. PubMed ID: 11592955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The renal hemodynamic effects of ibuprofen in the newborn rabbit.
    Chamaa NS; Mosig D; Drukker A; Guignard JP
    Pediatr Res; 2000 Nov; 48(5):600-5. PubMed ID: 11044478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cyclooxygenase-2-derived metabolites and nitric oxide in regulating renal function.
    Llinás MT; Rodríguez F; Moreno C; Salazar FJ
    Am J Physiol Regul Integr Comp Physiol; 2000 Nov; 279(5):R1641-6. PubMed ID: 11049846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal changes induced by a cyclooxygenase-2 inhibitor during normal and low sodium intake.
    Rodríguez F; Llinás MT; González JD; Rivera J; Salazar FJ
    Hypertension; 2000 Aug; 36(2):276-81. PubMed ID: 10948090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cyclooxygenase-2 in the prolonged regulation of renal function.
    Roig F; Llinás MT; López R; Salazar FJ
    Hypertension; 2002 Nov; 40(5):721-8. PubMed ID: 12411468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of celecoxib and diclofenac on blood pressure, renal function, and vasoactive prostanoids in young and elderly subjects.
    Dilger K; Herrlinger C; Peters J; Seyberth HW; Schweer H; Klotz U
    J Clin Pharmacol; 2002 Sep; 42(9):985-94. PubMed ID: 12211224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of losartan on renal function in the newborn rabbit.
    Prevot A; Mosig D; Guignard JP
    Pediatr Res; 2002 Jun; 51(6):728-32. PubMed ID: 12032268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of cyclooxygenase-2 (COX-2) reduces prostaglandin E2 production and attenuates systemic disease sequelae in experimental pancreatitis.
    Foitzik T; Hotz HG; Hotz B; Wittig F; Buhr HJ
    Hepatogastroenterology; 2003; 50(52):1159-62. PubMed ID: 12846004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective cyclooxygenase-2 inhibition by nimesulide in man.
    Cullen L; Kelly L; Connor SO; Fitzgerald DJ
    J Pharmacol Exp Ther; 1998 Nov; 287(2):578-82. PubMed ID: 9808683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal and cardiovascular effects of selective cyclooxygenase-2 inhibitors.
    Komers R; Anderson S; Epstein M
    Am J Kidney Dis; 2001 Dec; 38(6):1145-57. PubMed ID: 11728945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal functional responses to ischaemia-reperfusion injury in normotensive and hypertensive rats following non-selective and selective cyclo-oxygenase inhibition with nitric oxide donation.
    Knight S; Johns EJ
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):11-6. PubMed ID: 18047621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of selective cyclooxygenase-2 inhibitor on proliferation of human gastric cancer cells].
    Li JY; Yu JP; Luo HS; Yu BP; Tian G; Mei Q; Huang JA
    Ai Zheng; 2002 Jun; 21(6):625-9. PubMed ID: 12452063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II.
    Qi Z; Hao CM; Langenbach RI; Breyer RM; Redha R; Morrow JD; Breyer MD
    J Clin Invest; 2002 Jul; 110(1):61-9. PubMed ID: 12093889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects.
    Rossat J; Maillard M; Nussberger J; Brunner HR; Burnier M
    Clin Pharmacol Ther; 1999 Jul; 66(1):76-84. PubMed ID: 10430112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The adverse renal effects of prostaglandin-synthesis inhibitors in the newborn rabbit.
    Guignard JP
    Semin Perinatol; 2002 Dec; 26(6):398-405. PubMed ID: 12537310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 inhibition normalizes arterial blood pressure in CYP1A1-REN2 transgenic rats with inducible ANG II-dependent malignant hypertension.
    Opay AL; Mouton CR; Mullins JJ; Mitchell KD
    Am J Physiol Renal Physiol; 2006 Sep; 291(3):F612-8. PubMed ID: 16622181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nimesulide on constitutive and inducible prostanoid biosynthesis in human beings.
    Panara MR; Padovano R; Sciulli MG; Santini G; Renda G; Rotondo MT; Pace A; Patrono C; Patrignani P
    Clin Pharmacol Ther; 1998 Jun; 63(6):672-81. PubMed ID: 9663182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome: therapeutic use of the cyclooxygenase-2 inhibitor nimesulide.
    Nüsing RM; Reinalter SC; Peters M; Kömhoff M; Seyberth HW
    Clin Pharmacol Ther; 2001 Oct; 70(4):384-90. PubMed ID: 11673754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of cyclooxygenase-2 inhibition on renal hemodynamic function in humans with type 1 diabetes.
    Cherney DZ; Miller JA; Scholey JW; Bradley TJ; Slorach C; Curtis JR; Dekker MG; Nasrallah R; Hébert RL; Sochett EB
    Diabetes; 2008 Mar; 57(3):688-95. PubMed ID: 18083781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.